Record Information |
---|
Version | 5.0 |
---|
Status | Detected but not Quantified |
---|
Creation Date | 2021-09-11 06:55:39 UTC |
---|
Update Date | 2021-09-26 23:01:08 UTC |
---|
HMDB ID | HMDB0249962 |
---|
Secondary Accession Numbers | None |
---|
Metabolite Identification |
---|
Common Name | N-{(2R)-2-Hydroxy-2-[(8S,11S)-8-isopropyl-6,9-dioxo-2-oxa-7,10-diazabicyclo[11.2.2]heptadeca-1(15),13,16-trien-11-YL]ethyl}-N-isopentylbenzenesulfonamide |
---|
Description | N-{(2R)-2-Hydroxy-2-[(8S,11S)-8-isopropyl-6,9-dioxo-2-oxa-7,10-diazabicyclo[11.2.2]heptadeca-1(15),13,16-trien-11-YL]ethyl}-N-isopentylbenzenesulfonamide, also known as N-{2-[6,9-dihydroxy-8-(propan-2-yl)-2-oxa-7,10-diazabicyclo[11.2.2]heptadeca-1(15),6,9,13,16-pentaen-11-yl]-2-hydroxyethyl}-N-(3-methylbutyl)benzenesulphonamide, belongs to the class of organic compounds known as macrolactams. These are cyclic amides of amino carboxylic acids, having a 1-azacycloalkan-2-one structure, or analogues having unsaturation or heteroatoms replacing one or more carbon atoms of the ring. They are nitrogen analogues (the a nitrogen atom replacing the o atom of the cyclic carboxylic acid group ) of the naturally occurring macrolides. Based on a literature review very few articles have been published on N-{(2R)-2-Hydroxy-2-[(8S,11S)-8-isopropyl-6,9-dioxo-2-oxa-7,10-diazabicyclo[11.2.2]heptadeca-1(15),13,16-trien-11-YL]ethyl}-N-isopentylbenzenesulfonamide. This compound has been identified in human blood as reported by (PMID: 31557052 ). N-{(2r)-2-hydroxy-2-[(8s,11s)-8-isopropyl-6,9-dioxo-2-oxa-7,10-diazabicyclo[11.2.2]heptadeca-1(15),13,16-trien-11-yl]ethyl}-n-isopentylbenzenesulfonamide is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically N-{(2R)-2-Hydroxy-2-[(8S,11S)-8-isopropyl-6,9-dioxo-2-oxa-7,10-diazabicyclo[11.2.2]heptadeca-1(15),13,16-trien-11-YL]ethyl}-N-isopentylbenzenesulfonamide is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
---|
Structure | CC(C)CCN(CC(O)C1CC2=CC=C(OCCCC(=O)NC(C(C)C)C(=O)N1)C=C2)S(=O)(=O)C1=CC=CC=C1 InChI=1S/C30H43N3O6S/c1-21(2)16-17-33(40(37,38)25-9-6-5-7-10-25)20-27(34)26-19-23-12-14-24(15-13-23)39-18-8-11-28(35)32-29(22(3)4)30(36)31-26/h5-7,9-10,12-15,21-22,26-27,29,34H,8,11,16-20H2,1-4H3,(H,31,36)(H,32,35) |
---|
Synonyms | Value | Source |
---|
N-{(2R)-2-hydroxy-2-[(8S,11S)-8-isopropyl-6,9-dioxo-2-oxa-7,10-diazabicyclo[11.2.2]heptadeca-1(15),13,16-trien-11-yl]ethyl}-N-isopentylbenzenesulphonamide | Generator | N-{2-[6,9-dihydroxy-8-(propan-2-yl)-2-oxa-7,10-diazabicyclo[11.2.2]heptadeca-1(15),6,9,13,16-pentaen-11-yl]-2-hydroxyethyl}-N-(3-methylbutyl)benzenesulphonamide | HMDB |
|
---|
Chemical Formula | C30H43N3O6S |
---|
Average Molecular Weight | 573.75 |
---|
Monoisotopic Molecular Weight | 573.287257291 |
---|
IUPAC Name | N-{2-[6,9-dioxo-8-(propan-2-yl)-2-oxa-7,10-diazabicyclo[11.2.2]heptadeca-1(15),13,16-trien-11-yl]-2-hydroxyethyl}-N-(3-methylbutyl)benzenesulfonamide |
---|
Traditional Name | N-(2-hydroxy-2-{8-isopropyl-6,9-dioxo-2-oxa-7,10-diazabicyclo[11.2.2]heptadeca-1(15),13,16-trien-11-yl}ethyl)-N-(3-methylbutyl)benzenesulfonamide |
---|
CAS Registry Number | Not Available |
---|
SMILES | CC(C)CCN(CC(O)C1CC2=CC=C(OCCCC(=O)NC(C(C)C)C(=O)N1)C=C2)S(=O)(=O)C1=CC=CC=C1 |
---|
InChI Identifier | InChI=1S/C30H43N3O6S/c1-21(2)16-17-33(40(37,38)25-9-6-5-7-10-25)20-27(34)26-19-23-12-14-24(15-13-23)39-18-8-11-28(35)32-29(22(3)4)30(36)31-26/h5-7,9-10,12-15,21-22,26-27,29,34H,8,11,16-20H2,1-4H3,(H,31,36)(H,32,35) |
---|
InChI Key | WRUVOSYKHXGAQN-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as macrolactams. These are cyclic amides of amino carboxylic acids, having a 1-azacycloalkan-2-one structure, or analogues having unsaturation or heteroatoms replacing one or more carbon atoms of the ring. They are nitrogen analogues (the a nitrogen atom replacing the o atom of the cyclic carboxylic acid group ) of the naturally occurring macrolides. |
---|
Kingdom | Organic compounds |
---|
Super Class | Phenylpropanoids and polyketides |
---|
Class | Macrolactams |
---|
Sub Class | Not Available |
---|
Direct Parent | Macrolactams |
---|
Alternative Parents | |
---|
Substituents | - Macrolactam
- Alpha-amino acid or derivatives
- Benzenesulfonamide
- Benzenesulfonyl group
- Alkyl aryl ether
- Monocyclic benzene moiety
- Benzenoid
- Organosulfonic acid amide
- Aminosulfonyl compound
- Sulfonyl
- Organosulfonic acid or derivatives
- Organic sulfonic acid or derivatives
- Carboxamide group
- Lactam
- Secondary alcohol
- Secondary carboxylic acid amide
- Carboxylic acid derivative
- Ether
- Oxacycle
- Azacycle
- Organoheterocyclic compound
- Organic oxygen compound
- Organic nitrogen compound
- Alcohol
- Hydrocarbon derivative
- Carbonyl group
- Organic oxide
- Organonitrogen compound
- Organooxygen compound
- Organosulfur compound
- Organopnictogen compound
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredictor | Adduct Type | CCS Value (Å2) | Reference |
---|
DeepCCS | [M+H]+ | 231.097 | 30932474 | DeepCCS | [M-H]- | 228.701 | 30932474 | DeepCCS | [M-2H]- | 261.736 | 30932474 | DeepCCS | [M+Na]+ | 238.097 | 30932474 |
Predicted Kovats Retention IndicesUnderivatizedMetabolite | SMILES | Kovats RI Value | Column Type | Reference |
---|
N-{(2R)-2-Hydroxy-2-[(8S,11S)-8-isopropyl-6,9-dioxo-2-oxa-7,10-diazabicyclo[11.2.2]heptadeca-1(15),13,16-trien-11-YL]ethyl}-N-isopentylbenzenesulfonamide | CC(C)CCN(CC(O)C1CC2=CC=C(OCCCC(=O)NC(C(C)C)C(=O)N1)C=C2)S(=O)(=O)C1=CC=CC=C1 | 5726.7 | Standard polar | 33892256 | N-{(2R)-2-Hydroxy-2-[(8S,11S)-8-isopropyl-6,9-dioxo-2-oxa-7,10-diazabicyclo[11.2.2]heptadeca-1(15),13,16-trien-11-YL]ethyl}-N-isopentylbenzenesulfonamide | CC(C)CCN(CC(O)C1CC2=CC=C(OCCCC(=O)NC(C(C)C)C(=O)N1)C=C2)S(=O)(=O)C1=CC=CC=C1 | 4083.4 | Standard non polar | 33892256 | N-{(2R)-2-Hydroxy-2-[(8S,11S)-8-isopropyl-6,9-dioxo-2-oxa-7,10-diazabicyclo[11.2.2]heptadeca-1(15),13,16-trien-11-YL]ethyl}-N-isopentylbenzenesulfonamide | CC(C)CCN(CC(O)C1CC2=CC=C(OCCCC(=O)NC(C(C)C)C(=O)N1)C=C2)S(=O)(=O)C1=CC=CC=C1 | 4464.2 | Semi standard non polar | 33892256 |
DerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
N-{(2R)-2-Hydroxy-2-[(8S,11S)-8-isopropyl-6,9-dioxo-2-oxa-7,10-diazabicyclo[11.2.2]heptadeca-1(15),13,16-trien-11-YL]ethyl}-N-isopentylbenzenesulfonamide,2TMS,isomer #1 | CC(C)CCN(CC(O[Si](C)(C)C)C1CC2=CC=C(C=C2)OCCCC(=O)N([Si](C)(C)C)C(C(C)C)C(=O)N1)S(=O)(=O)C1=CC=CC=C1 | 4162.0 | Semi standard non polar | 33892256 | N-{(2R)-2-Hydroxy-2-[(8S,11S)-8-isopropyl-6,9-dioxo-2-oxa-7,10-diazabicyclo[11.2.2]heptadeca-1(15),13,16-trien-11-YL]ethyl}-N-isopentylbenzenesulfonamide,2TMS,isomer #1 | CC(C)CCN(CC(O[Si](C)(C)C)C1CC2=CC=C(C=C2)OCCCC(=O)N([Si](C)(C)C)C(C(C)C)C(=O)N1)S(=O)(=O)C1=CC=CC=C1 | 3971.0 | Standard non polar | 33892256 | N-{(2R)-2-Hydroxy-2-[(8S,11S)-8-isopropyl-6,9-dioxo-2-oxa-7,10-diazabicyclo[11.2.2]heptadeca-1(15),13,16-trien-11-YL]ethyl}-N-isopentylbenzenesulfonamide,2TMS,isomer #1 | CC(C)CCN(CC(O[Si](C)(C)C)C1CC2=CC=C(C=C2)OCCCC(=O)N([Si](C)(C)C)C(C(C)C)C(=O)N1)S(=O)(=O)C1=CC=CC=C1 | 5786.6 | Standard polar | 33892256 | N-{(2R)-2-Hydroxy-2-[(8S,11S)-8-isopropyl-6,9-dioxo-2-oxa-7,10-diazabicyclo[11.2.2]heptadeca-1(15),13,16-trien-11-YL]ethyl}-N-isopentylbenzenesulfonamide,2TMS,isomer #2 | CC(C)CCN(CC(O[Si](C)(C)C)C1CC2=CC=C(C=C2)OCCCC(=O)NC(C(C)C)C(=O)N1[Si](C)(C)C)S(=O)(=O)C1=CC=CC=C1 | 4194.6 | Semi standard non polar | 33892256 | N-{(2R)-2-Hydroxy-2-[(8S,11S)-8-isopropyl-6,9-dioxo-2-oxa-7,10-diazabicyclo[11.2.2]heptadeca-1(15),13,16-trien-11-YL]ethyl}-N-isopentylbenzenesulfonamide,2TMS,isomer #2 | CC(C)CCN(CC(O[Si](C)(C)C)C1CC2=CC=C(C=C2)OCCCC(=O)NC(C(C)C)C(=O)N1[Si](C)(C)C)S(=O)(=O)C1=CC=CC=C1 | 3992.8 | Standard non polar | 33892256 | N-{(2R)-2-Hydroxy-2-[(8S,11S)-8-isopropyl-6,9-dioxo-2-oxa-7,10-diazabicyclo[11.2.2]heptadeca-1(15),13,16-trien-11-YL]ethyl}-N-isopentylbenzenesulfonamide,2TMS,isomer #2 | CC(C)CCN(CC(O[Si](C)(C)C)C1CC2=CC=C(C=C2)OCCCC(=O)NC(C(C)C)C(=O)N1[Si](C)(C)C)S(=O)(=O)C1=CC=CC=C1 | 5856.0 | Standard polar | 33892256 | N-{(2R)-2-Hydroxy-2-[(8S,11S)-8-isopropyl-6,9-dioxo-2-oxa-7,10-diazabicyclo[11.2.2]heptadeca-1(15),13,16-trien-11-YL]ethyl}-N-isopentylbenzenesulfonamide,2TMS,isomer #3 | CC(C)CCN(CC(O)C1CC2=CC=C(C=C2)OCCCC(=O)N([Si](C)(C)C)C(C(C)C)C(=O)N1[Si](C)(C)C)S(=O)(=O)C1=CC=CC=C1 | 3988.6 | Semi standard non polar | 33892256 | N-{(2R)-2-Hydroxy-2-[(8S,11S)-8-isopropyl-6,9-dioxo-2-oxa-7,10-diazabicyclo[11.2.2]heptadeca-1(15),13,16-trien-11-YL]ethyl}-N-isopentylbenzenesulfonamide,2TMS,isomer #3 | CC(C)CCN(CC(O)C1CC2=CC=C(C=C2)OCCCC(=O)N([Si](C)(C)C)C(C(C)C)C(=O)N1[Si](C)(C)C)S(=O)(=O)C1=CC=CC=C1 | 4069.2 | Standard non polar | 33892256 | N-{(2R)-2-Hydroxy-2-[(8S,11S)-8-isopropyl-6,9-dioxo-2-oxa-7,10-diazabicyclo[11.2.2]heptadeca-1(15),13,16-trien-11-YL]ethyl}-N-isopentylbenzenesulfonamide,2TMS,isomer #3 | CC(C)CCN(CC(O)C1CC2=CC=C(C=C2)OCCCC(=O)N([Si](C)(C)C)C(C(C)C)C(=O)N1[Si](C)(C)C)S(=O)(=O)C1=CC=CC=C1 | 5651.6 | Standard polar | 33892256 | N-{(2R)-2-Hydroxy-2-[(8S,11S)-8-isopropyl-6,9-dioxo-2-oxa-7,10-diazabicyclo[11.2.2]heptadeca-1(15),13,16-trien-11-YL]ethyl}-N-isopentylbenzenesulfonamide,3TMS,isomer #1 | CC(C)CCN(CC(O[Si](C)(C)C)C1CC2=CC=C(C=C2)OCCCC(=O)N([Si](C)(C)C)C(C(C)C)C(=O)N1[Si](C)(C)C)S(=O)(=O)C1=CC=CC=C1 | 4049.2 | Semi standard non polar | 33892256 | N-{(2R)-2-Hydroxy-2-[(8S,11S)-8-isopropyl-6,9-dioxo-2-oxa-7,10-diazabicyclo[11.2.2]heptadeca-1(15),13,16-trien-11-YL]ethyl}-N-isopentylbenzenesulfonamide,3TMS,isomer #1 | CC(C)CCN(CC(O[Si](C)(C)C)C1CC2=CC=C(C=C2)OCCCC(=O)N([Si](C)(C)C)C(C(C)C)C(=O)N1[Si](C)(C)C)S(=O)(=O)C1=CC=CC=C1 | 4137.0 | Standard non polar | 33892256 | N-{(2R)-2-Hydroxy-2-[(8S,11S)-8-isopropyl-6,9-dioxo-2-oxa-7,10-diazabicyclo[11.2.2]heptadeca-1(15),13,16-trien-11-YL]ethyl}-N-isopentylbenzenesulfonamide,3TMS,isomer #1 | CC(C)CCN(CC(O[Si](C)(C)C)C1CC2=CC=C(C=C2)OCCCC(=O)N([Si](C)(C)C)C(C(C)C)C(=O)N1[Si](C)(C)C)S(=O)(=O)C1=CC=CC=C1 | 5345.9 | Standard polar | 33892256 | N-{(2R)-2-Hydroxy-2-[(8S,11S)-8-isopropyl-6,9-dioxo-2-oxa-7,10-diazabicyclo[11.2.2]heptadeca-1(15),13,16-trien-11-YL]ethyl}-N-isopentylbenzenesulfonamide,2TBDMS,isomer #1 | CC(C)CCN(CC(O[Si](C)(C)C(C)(C)C)C1CC2=CC=C(C=C2)OCCCC(=O)N([Si](C)(C)C(C)(C)C)C(C(C)C)C(=O)N1)S(=O)(=O)C1=CC=CC=C1 | 4656.6 | Semi standard non polar | 33892256 | N-{(2R)-2-Hydroxy-2-[(8S,11S)-8-isopropyl-6,9-dioxo-2-oxa-7,10-diazabicyclo[11.2.2]heptadeca-1(15),13,16-trien-11-YL]ethyl}-N-isopentylbenzenesulfonamide,2TBDMS,isomer #1 | CC(C)CCN(CC(O[Si](C)(C)C(C)(C)C)C1CC2=CC=C(C=C2)OCCCC(=O)N([Si](C)(C)C(C)(C)C)C(C(C)C)C(=O)N1)S(=O)(=O)C1=CC=CC=C1 | 4372.8 | Standard non polar | 33892256 | N-{(2R)-2-Hydroxy-2-[(8S,11S)-8-isopropyl-6,9-dioxo-2-oxa-7,10-diazabicyclo[11.2.2]heptadeca-1(15),13,16-trien-11-YL]ethyl}-N-isopentylbenzenesulfonamide,2TBDMS,isomer #1 | CC(C)CCN(CC(O[Si](C)(C)C(C)(C)C)C1CC2=CC=C(C=C2)OCCCC(=O)N([Si](C)(C)C(C)(C)C)C(C(C)C)C(=O)N1)S(=O)(=O)C1=CC=CC=C1 | 5768.7 | Standard polar | 33892256 | N-{(2R)-2-Hydroxy-2-[(8S,11S)-8-isopropyl-6,9-dioxo-2-oxa-7,10-diazabicyclo[11.2.2]heptadeca-1(15),13,16-trien-11-YL]ethyl}-N-isopentylbenzenesulfonamide,2TBDMS,isomer #2 | CC(C)CCN(CC(O[Si](C)(C)C(C)(C)C)C1CC2=CC=C(C=C2)OCCCC(=O)NC(C(C)C)C(=O)N1[Si](C)(C)C(C)(C)C)S(=O)(=O)C1=CC=CC=C1 | 4708.1 | Semi standard non polar | 33892256 | N-{(2R)-2-Hydroxy-2-[(8S,11S)-8-isopropyl-6,9-dioxo-2-oxa-7,10-diazabicyclo[11.2.2]heptadeca-1(15),13,16-trien-11-YL]ethyl}-N-isopentylbenzenesulfonamide,2TBDMS,isomer #2 | CC(C)CCN(CC(O[Si](C)(C)C(C)(C)C)C1CC2=CC=C(C=C2)OCCCC(=O)NC(C(C)C)C(=O)N1[Si](C)(C)C(C)(C)C)S(=O)(=O)C1=CC=CC=C1 | 4401.3 | Standard non polar | 33892256 | N-{(2R)-2-Hydroxy-2-[(8S,11S)-8-isopropyl-6,9-dioxo-2-oxa-7,10-diazabicyclo[11.2.2]heptadeca-1(15),13,16-trien-11-YL]ethyl}-N-isopentylbenzenesulfonamide,2TBDMS,isomer #2 | CC(C)CCN(CC(O[Si](C)(C)C(C)(C)C)C1CC2=CC=C(C=C2)OCCCC(=O)NC(C(C)C)C(=O)N1[Si](C)(C)C(C)(C)C)S(=O)(=O)C1=CC=CC=C1 | 5879.5 | Standard polar | 33892256 | N-{(2R)-2-Hydroxy-2-[(8S,11S)-8-isopropyl-6,9-dioxo-2-oxa-7,10-diazabicyclo[11.2.2]heptadeca-1(15),13,16-trien-11-YL]ethyl}-N-isopentylbenzenesulfonamide,2TBDMS,isomer #3 | CC(C)CCN(CC(O)C1CC2=CC=C(C=C2)OCCCC(=O)N([Si](C)(C)C(C)(C)C)C(C(C)C)C(=O)N1[Si](C)(C)C(C)(C)C)S(=O)(=O)C1=CC=CC=C1 | 4593.8 | Semi standard non polar | 33892256 | N-{(2R)-2-Hydroxy-2-[(8S,11S)-8-isopropyl-6,9-dioxo-2-oxa-7,10-diazabicyclo[11.2.2]heptadeca-1(15),13,16-trien-11-YL]ethyl}-N-isopentylbenzenesulfonamide,2TBDMS,isomer #3 | CC(C)CCN(CC(O)C1CC2=CC=C(C=C2)OCCCC(=O)N([Si](C)(C)C(C)(C)C)C(C(C)C)C(=O)N1[Si](C)(C)C(C)(C)C)S(=O)(=O)C1=CC=CC=C1 | 4465.6 | Standard non polar | 33892256 | N-{(2R)-2-Hydroxy-2-[(8S,11S)-8-isopropyl-6,9-dioxo-2-oxa-7,10-diazabicyclo[11.2.2]heptadeca-1(15),13,16-trien-11-YL]ethyl}-N-isopentylbenzenesulfonamide,2TBDMS,isomer #3 | CC(C)CCN(CC(O)C1CC2=CC=C(C=C2)OCCCC(=O)N([Si](C)(C)C(C)(C)C)C(C(C)C)C(=O)N1[Si](C)(C)C(C)(C)C)S(=O)(=O)C1=CC=CC=C1 | 5645.5 | Standard polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - N-{(2R)-2-Hydroxy-2-[(8S,11S)-8-isopropyl-6,9-dioxo-2-oxa-7,10-diazabicyclo[11.2.2]heptadeca-1(15),13,16-trien-11-YL]ethyl}-N-isopentylbenzenesulfonamide GC-MS (TMS_1_1) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - N-{(2R)-2-Hydroxy-2-[(8S,11S)-8-isopropyl-6,9-dioxo-2-oxa-7,10-diazabicyclo[11.2.2]heptadeca-1(15),13,16-trien-11-YL]ethyl}-N-isopentylbenzenesulfonamide GC-MS (TMS_1_2) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - N-{(2R)-2-Hydroxy-2-[(8S,11S)-8-isopropyl-6,9-dioxo-2-oxa-7,10-diazabicyclo[11.2.2]heptadeca-1(15),13,16-trien-11-YL]ethyl}-N-isopentylbenzenesulfonamide GC-MS (TMS_1_3) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - N-{(2R)-2-Hydroxy-2-[(8S,11S)-8-isopropyl-6,9-dioxo-2-oxa-7,10-diazabicyclo[11.2.2]heptadeca-1(15),13,16-trien-11-YL]ethyl}-N-isopentylbenzenesulfonamide GC-MS (TBDMS_1_1) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - N-{(2R)-2-Hydroxy-2-[(8S,11S)-8-isopropyl-6,9-dioxo-2-oxa-7,10-diazabicyclo[11.2.2]heptadeca-1(15),13,16-trien-11-YL]ethyl}-N-isopentylbenzenesulfonamide GC-MS (TBDMS_1_2) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - N-{(2R)-2-Hydroxy-2-[(8S,11S)-8-isopropyl-6,9-dioxo-2-oxa-7,10-diazabicyclo[11.2.2]heptadeca-1(15),13,16-trien-11-YL]ethyl}-N-isopentylbenzenesulfonamide GC-MS (TBDMS_1_3) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N-{(2R)-2-Hydroxy-2-[(8S,11S)-8-isopropyl-6,9-dioxo-2-oxa-7,10-diazabicyclo[11.2.2]heptadeca-1(15),13,16-trien-11-YL]ethyl}-N-isopentylbenzenesulfonamide 10V, Positive-QTOF | splash10-00di-0300390000-e64c3ea0c1c8b9b1dbce | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N-{(2R)-2-Hydroxy-2-[(8S,11S)-8-isopropyl-6,9-dioxo-2-oxa-7,10-diazabicyclo[11.2.2]heptadeca-1(15),13,16-trien-11-YL]ethyl}-N-isopentylbenzenesulfonamide 20V, Positive-QTOF | splash10-0006-2902240000-9918f0ef79e4926bcdb5 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N-{(2R)-2-Hydroxy-2-[(8S,11S)-8-isopropyl-6,9-dioxo-2-oxa-7,10-diazabicyclo[11.2.2]heptadeca-1(15),13,16-trien-11-YL]ethyl}-N-isopentylbenzenesulfonamide 40V, Positive-QTOF | splash10-0i2d-9747400000-c0d527433ac09595f776 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N-{(2R)-2-Hydroxy-2-[(8S,11S)-8-isopropyl-6,9-dioxo-2-oxa-7,10-diazabicyclo[11.2.2]heptadeca-1(15),13,16-trien-11-YL]ethyl}-N-isopentylbenzenesulfonamide 10V, Negative-QTOF | splash10-0fk9-0000090000-d6477b9abd27cda92176 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N-{(2R)-2-Hydroxy-2-[(8S,11S)-8-isopropyl-6,9-dioxo-2-oxa-7,10-diazabicyclo[11.2.2]heptadeca-1(15),13,16-trien-11-YL]ethyl}-N-isopentylbenzenesulfonamide 20V, Negative-QTOF | splash10-0ffx-0690050000-bf8f5faeb3053c09516b | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N-{(2R)-2-Hydroxy-2-[(8S,11S)-8-isopropyl-6,9-dioxo-2-oxa-7,10-diazabicyclo[11.2.2]heptadeca-1(15),13,16-trien-11-YL]ethyl}-N-isopentylbenzenesulfonamide 40V, Negative-QTOF | splash10-0006-0920000000-1f241d6d82cdb8d8f9f0 | 2021-10-12 | Wishart Lab | View Spectrum |
|
---|